Table 5. Meta-regression of baseline characters for incident diabetes.
logor | t | P>|t| | [95% Conf. Interval] |
age | 2.54 | 0.026 | 1.002305 1.030816 |
sex | −2.34 | 0.038 | .9912401.9996951 |
target LDL | −3.40 | 0.005 | .7582104.941228 |
baseline LDL | −2.45 | 0.031 | .771076.9849836 |
baseline cholesterol | −2.41 | 0.034 | .7478781.9867268 |
LDL reduction | 2.25 | 0.044 | 1.000208 1.013721 |
dose | 1.25 | 0.235 | .9979259 1.007709 |
BMI | 1.29 | 0.224 | .9773928 1.091429 |
CHD | −1.21 | 0.250 | .9971045 1.000831 |
stroke | 2.37 | 0.064 | .9995688 1.010495 |
hypertension | 0.98 | 0.346 | .9983291 1.004423 |
systolic BP | 0.69 | 0.506 | .9939916 1.011491 |
diastolic BP | 0.05 | 0.962 | .9809797 1.020278 |
smoking | −0.34 | 0.742 | .987824 1.009013 |
baseline HDL | 1.87 | 0.088 | .9145669 3.037582 |
baseline triglycerides | −0.85 | 0.414 | .8823282 1.057124 |
Aspirin | −0.23 | 0.823 | .9957346 1.003503 |
Aceinhibitor | 0.38 | 0.718 | .9945277 1.007432 |
Beta-block | −0.46 | 0.663 | .9929148 1.004881 |
HDL Increase | −0.75 | 0.470 | .9485923 1.026537 |
cholesterol reduction | 0.82 | 0.437 | .987558 1.02625 |
triglycerides reduction | 0.36 | 0.726 | .9799687 1.028448 |